Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Experimental setup
From: Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Week | Action | Cohort 1 (N = 12) | Cohort 2 (N = 12) | Cohort 3 (N = 12) |
|---|---|---|---|---|
0 | Patient’s recruitment/assessment/randomization. Any treatment discontinuation | |||
1 | VAS assessment | Starts treatment C | Starts treatment C + P | Starts treatment P |
5 | Treatment discontinuation and VAS assessment | |||
6 | VAS assessment | Starts treatment P | Starts treatment C | Starts treatment C + P |
10 | Treatment discontinuation and VAS assessment | |||
11 | VAS assessment | Starts treatment P + C | Starts treatment P | Starts treatment C |
15 | Treatment discontinuation and VAS assessment | |||